Endocyte: Endocyte, Inc. (NASDAQ:ECYT) Files An 8-K Results of Operations and Financial Condition
Endocyte, Inc. (the “Company”) announced its results of operations for the three months ended September 30, 2018.
Read full article »
CEO
Endocyte develops small molecule drug conjugation therapies for the personalized treatment of cancer.
Read more